Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Assets    
Cash and cash equivalents $ 21,729 $ 3,926
Restricted cash 7,213 63
Accounts receivable, net 6,792 4,631
Inventories, net 5,245 4,869
Prepaid expenses and other current assets 2,940 4,074
Total Current Assets 43,919 17,563
Fixed assets, net 369 252
Right-of-use assets, operating leases 56 345
Intangible assets, net 11,586 13,115
Goodwill 18,614 18,614
Other assets 116 1,364
Total Assets 74,660 51,253
Current Liabilities    
Accounts payable 4,553 3,137
Accrued and other liabilities 1,879 3,400
Term loans, net 855 7,826
PPP loans 0 190
Operating lease liability 54 173
Warrant liability 0 39,850
Total Current Liabilities 7,341 54,576
Non-current Liabilities    
Term loans, net 4,559 0
Line of credit, net 4,856 5,023
Deferred tax liability 24 0
Operating lease liability 5 184
Notes payable, net 0 18,910
PPP loans 0 662
Total Non-current Liabilities 9,444 24,779
Total Liabilities 16,785 79,355
Stockholders’ Equity (Deficit)    
Common Stock, $0.001 par value, 200,000,000 shares authorized, 29,146,367 & 8,651,400 shares issued and outstanding as of December 31, 2021 and 2020, respectively 29 9
Series F Preferred Stock, $0.001 par value, 30,000 shares authorized, 0 shares & 21,754 shares issued and outstanding as of December 31, 2021 and 2020, respectively 0 0
Additional paid-in capital 317,102 232,530
Accumulated deficit (259,256) (260,641)
Total Stockholders’ Equity (Deficit) 57,875 (28,102)
Total Liabilities and Stockholders’ Equity (Deficit) $ 74,660 $ 51,253